Skip to main content

Please enter a keyword and click the arrow to search the site

Roslin Biomed (A)

Subject

Strategy and Entrepreneurship, Strategy and Entrepreneurship

Authors / Editors

Tansley R;Birkinshaw J;Murray G

Publication Year

2002

Abstract

This case focuses on the formation of Roslin Biomed, a spin-off from the Roslin Institute that was formed to commercialise the nuclear transfer technology behind the successful cloning of Dolly the sheep. The case describes the background to the birth of Dolly and then follows the subsequent events - The establishment of Roslin Biomed, the recruitment of Simon Best as Chief Executive of the company and his discussions with various partner companies.

Topic List

Technology Transfer, Knowledge Management, Acquistition

Industry

Biotech

Publication Event Date

1999

LBS Case Number

CS-02-005

Location

Edinburgh

Publication Organisation Size

Small - Medium

Project Funder

Fondation Banque De France

Publication Research Centre

Institute of Finance and Accounting

Available on ECCH

No


Select up to 4 programmes to compare

Select one more to compare
×
subscribe_image_desktop 5949B9BFE33243D782D1C7A17E3345D0

Sign up to receive our latest news and business thinking direct to your inbox

×

Sign up to receive our latest course information and business thinking

Leave your details above if you would like to receive emails containing the latest thought leadership, invitations to events and news about courses that could enhance your career. If you would prefer not to receive our emails, you can still access the case study by clicking the button below. You can opt-out of receiving our emails at any time by visiting: https://london.edu/my-profile-preferences or by unsubscribing through the link provided in our emails. View our Privacy Policy for more information on your rights.